Canada's Nordion Inc, a major provider of medical isotopes, said on Monday it has hired advisers to examine options for its future, sending its shares sharply higher.The company said no decision had been made on a deal and it intends to continue with planned business activities during the strategic review.Jefferies & Company will advise the company in the review.Nordion suspended its dividend in September after an arbitration panel rejected its claim for damages from its main supplier, state-owned Atomic Energy of Canada Ltd.
Nordion Inc. (Nordion), formerly MDS Inc. is a global life sciences company that provides products and services for the prevention, diagnosis and treatment of disease. Shares of NDZ traded higher by 11.11% or $0.71/share to $7.10. In the past year, the shares have traded as low as $5.51 and as high as $10.96. On average, 139495 shares of NDZ exchange hands on a given day and today's volume is recorded at 523433.
Source
